In an older adult (≥ 65 years) with moderate acute or chronic nociceptive pain not controlled by non‑opioid analgesics, how does tramadol compare to codeine regarding efficacy, dosing, safety, and appropriate use?

Tramadol vs Codeine in Pain Management in Older Adults

For older adults ≥65 years with moderate pain not controlled by non-opioid analgesics, codeine is generally preferred over tramadol due to better tolerability, lower rates of adverse effects (particularly dizziness and vomiting), and more predictable efficacy, though both require careful dose adjustments for age and renal function.

Key Pharmacological Differences

Tramadol Characteristics

• Mechanism: Weak mu-opioid receptor agonist (~1/10th potency of morphine) with dual action via norepinephrine and serotonin reuptake inhibition 1
• Metabolism: Highly variable due to CYP2D6 dependence—essentially ineffective in poor metabolizers (~7% of population) and potentially toxic in ultrarapid metabolizers 1, 2
• Dosing in older adults:
  • Ages 65-74: Standard dosing up to 400 mg/day (IR) or 300 mg/day (ER)
  • Ages ≥75: Maximum 300 mg/day total 1, 2
  • Creatinine clearance <30 mL/min: 100 mg every 12 hours (max 200 mg/day) 2

Codeine Characteristics

• Mechanism: Prodrug requiring CYP2D6 metabolism to morphine for analgesic effect 3
• Efficacy: More effective than placebo for cancer pain but also CYP2D6-dependent 3
• Genetic considerations: Ineffective in poor metabolizers, potentially toxic in ultrarapid metabolizers 1

Comparative Efficacy Evidence

Direct Comparison Studies

A 4-week randomized trial (n=462, mean age 57.6 years) comparing tramadol/acetaminophen (37.5/325 mg) versus codeine/acetaminophen (30/300 mg) for chronic low back pain and osteoarthritis found:

• Equivalent pain relief and pain intensity reduction
• Similar efficacy ratings by patients and investigators
• Equivalent dosing requirements (mean 3.5 tablets/capsules daily) 4

However, tolerability favored codeine:

• Tramadol group: Higher headache rates (11% vs 7%)
• Codeine group: Higher somnolence (24% vs 17%, p=0.05) and constipation (21% vs 11%, p<0.01) 4

A smaller Italian study (n=38, mean age 64.7 years) over 4 weeks found codeine-paracetamol demonstrated slightly better pain improvement and was better tolerated with fewer adverse events and dropouts compared to tramadol-paracetamol 5.

Clinical Practice Patterns

Real-world prescribing data from hand surgery patients showed tramadol required significantly more prescription refills than codeine, suggesting inadequate pain control or tolerance issues 6.

Safety Profile in Older Adults

Tramadol-Specific Risks

Critical warnings for older adults:

• Seizure risk: Increased with doses >300 mg/day, especially in those ≥75 years, hepatic/renal dysfunction 1, 7, 2
• Serotonin syndrome: When combined with SSRIs, SNRIs, TCAs, or MAOIs—particularly dangerous in elderly 1, 3, 1
• Adverse effects: Higher rates of dizziness, nausea, vomiting, and weakness compared to codeine and hydrocodone in cancer pain studies 1, 7
• Variable metabolism: Marked unpredictability due to CYP2D6 polymorphisms 1

Codeine-Specific Risks

• Constipation: More common than tramadol (21% vs 11%) 8, 4
• Somnolence: Higher rates than tramadol (24% vs 17%) 4
• CYP2D6 dependency: Ineffective in poor metabolizers, toxic in ultrarapid metabolizers 3, 1
• Respiratory depression: Lower risk than stronger opioids but still present 9

Practical Prescribing Algorithm for Older Adults

Step 1: Patient Assessment

Check for absolute contraindications:

• Tramadol: Current use of SSRIs, SNRIs, TCAs, MAOIs, or seizure history
• Codeine: Known CYP2D6 poor or ultrarapid metabolizer status
• Both: Severe respiratory disease, acute alcohol intoxication

Assess renal function (critical for both agents):

• CrCl <30 mL/min: Tramadol requires 12-hour dosing interval, max 200 mg/day 2
• Codeine: Also requires dose reduction in renal impairment

Step 2: Drug Selection

Choose CODEINE if:

• Patient is on antidepressants (SSRIs, SNRIs, TCAs)
• Seizure history or risk factors present
• Constipation is manageable (prophylactic laxatives acceptable)
• Patient age 65-85 years with normal cognition

Choose TRAMADOL if:

• Severe constipation is a major concern
• Patient cannot tolerate sedation
• Neuropathic pain component present (dual mechanism may help)
• BUT avoid if age ≥75 years unless no alternatives 1, 2

Consider NEITHER if:

• CYP2D6 testing reveals poor or ultrarapid metabolizer status 1
• Multiple contraindications present
• Consider alternative: morphine, oxycodone, or hydromorphone with appropriate dose adjustments 1

Step 3: Initial Dosing

Tramadol (if selected):

• Ages 65-74: Start 25-50 mg every 6 hours, titrate by 25-50 mg every 3 days
• Ages ≥75: Start 25 mg every 6-8 hours, max 300 mg/day total 1, 2
• Renal impairment (CrCl <30): 50 mg every 12 hours, max 200 mg/day 2

Codeine (if selected):

• Start 15-30 mg every 4-6 hours as needed
• Typically combined with acetaminophen 300-500 mg
• Titrate cautiously based on response
• Always prescribe prophylactic laxatives 8

Step 4: Monitoring

First week:

• Daily assessment of pain relief and adverse effects
• Specific attention to: dizziness, falls, confusion, nausea, constipation
• Tramadol: Monitor for serotonin syndrome symptoms (agitation, tremor, hyperthermia)

Ongoing (every 1-2 weeks):

• Pain intensity and functional improvement
• Adverse effects requiring dose adjustment or discontinuation
• Need for rescue medication (suggests inadequate control)
• Reassess need for continued opioid therapy monthly 10, 11

Common Pitfalls to Avoid

1. Ignoring CYP2D6 status: Both drugs are essentially ineffective in poor metabolizers—consider pharmacogenomic testing if available 1

2. Exceeding age-specific dose limits: Tramadol >300 mg/day in patients ≥75 years significantly increases seizure risk 1, 2

3. Combining tramadol with antidepressants: High risk of serotonin syndrome, especially in elderly 1, 3, 1

4. Failing to adjust for renal function: Both drugs accumulate with reduced clearance 2

5. Not prescribing laxatives with codeine: Constipation is predictable and should be prevented, not treated reactively 8, 4

6. Assuming equivalence: Despite similar opioid potency, clinical outcomes differ—tramadol requires more refills and has higher discontinuation rates 5, 6

Special Considerations

Cancer Pain

Both agents are considered suboptimal for cancer pain 1, 3:

• Tramadol: Limited evidence, likely less effective than morphine, higher adverse effects than hydrocodone/codeine 1, 7
• Codeine: More effective than placebo but inferior to stronger opioids 3
• Recommendation: Consider moving directly to low-dose morphine, oxycodone, or hydromorphone rather than prolonged trials of weak opioids 3

Neuropathic Pain Component

• Tramadol's dual mechanism (opioid + monoamine reuptake inhibition) may provide theoretical advantage 1
• However, gabapentinoids or duloxetine are preferred first-line agents for neuropathic pain in older adults 12, 13
• If opioid needed, tramadol may be considered but with heightened caution regarding drug interactions 13

Polypharmacy Context

In older adults taking multiple medications 11, 12:

• Codeine is safer with fewer drug-drug interactions (except CYP2D6 inhibitors)
• Tramadol has extensive interaction potential via serotonergic mechanisms and CYP2D6/3A4 metabolism 1, 2

Duration of Therapy

Both agents should be time-limited 11, 13:

• Acute pain: Maximum 7-14 days
• Chronic pain: Regular reassessment every 4 weeks
• If inadequate pain control after 4 weeks, rotate to alternative opioid rather than escalating dose 3
• Consider non-pharmacological interventions and multimodal analgesia throughout 10, 12

1, 7, 3, 1, 7, 1, 8, 10, 11, 2, 5, 4, 6, 9, 12, 13